Resources and further reading

  • Microbiology Today: Vaccines

    In this issue of Microbiology Today we will explore the future of vaccines, including the potential to develop an oral vaccine for typhoid fever; challenges that the malaria vaccine faces, and approaches to advancing DNA vaccine technology.

  • Coronavirus journal collection

    Coronaviruses are a large family of viruses that can infect a range of hosts. To allow the widest possible distribution of relevant research, the Microbiology Society has brought together articles from across our portfolio and made this content freely available.

  • Ebola Virus Disease journal collection

    This collection brings together articles from our portfolio of journals on Ebola virus disease. The Microbiology Society has made this content freely available in the interests of widest possible distribution of relevant research.

  • Epstein–Barr virus: opportunities for prophylactic and therapeutic vaccines

    Given that it infects over 90% of people worldwide, Epstein–Barr Virus (EBV) is a highly successful pathogen. In this article, we explore opportunities for prophylactic and therapeutic vaccines.

  • A new vaccine against tuberculosis

    In this Microbiology Today issue we explore the challenges and strategies of developing a new vaccine against tuberculosis.

  • New vaccine developed for infectious laryngotracheitis

    A new vaccine has been developed for an important chicken disease. Infectious laryngotracheitis (ILT) is caused by virus that targets the respiratory system of chickens. Infected chickens have reduced egg-production, weight loss and in severe cases, ILT is fatal.

  • ‘Hypervirulent’ disease a burden on aquaculture

    Researchers have been using a combination of probiotics and vaccines to try and reduce the spread of a deadly fish disease.

  • Vaccines: from the cowshed to the clinic

    Vaccines are an essential component of public health, keeping people safe against disease. But how do they work, how are they manufactured and what are the challenges involved? We spoke to Dr Sarah Gilbert from the Jenner Institute to find out more.

  • A bump in the road for a broad-spectrum flu vaccine?

    Although flu vaccines can take time to produce, they are the best way to prevent an infection. The problem is that today’s vaccines only protect against a specific viral strain and its close relatives. The strains constantly change, so repeated immunisation are required. We explore more about this issue in our blog.

  • JMM Editor's Choice: Developing vaccines against Staphylococcus epidermidis

    This manuscript describes data that could provide a promising approach to fight staphylococcal infections.

  • Ebola in great apes and building health infrastructure

    In this podcast we discuss Ebola vaccines for chimpanzees and engineering the built environment to prevent the spread of infections.


Image credits:
Goodshoot / Creatas 
"MERS-CoV" by NIAID is licensed under CC BY 2.0, this image has been modified.
Science Photo Library
Dr Linda Stannard/Science Photo Library
monticelllo/iStock
ai_yoshi/iStock
Wellcome Collection under CC BY 4.0
Manjurul/iStock
Thinkstock
wrangel/Thinkstock
jaddingt/Shutterstock